Rapidly Progressive Rhino-Orbital Mucormycosis in a Diabetic Patient: A Fatal Outcome

Abstract

One of the most severe and quickly spreading types of fungal infections is mucormycosis, which typically starts in the nose and paranasal sinuses after fungal spores are inhaled. It is brought on by organisms belonging to the subphylum Mucormycotina, which includes genera like Absidia, Rhizomucor, Rhizopus, and Mucor. Every year, there are roughly 1 in 7 cases of mucormycosis for every 1,000,000 people. Because the maxillofacial regions have a rich blood vessel supply, mucormycosis affecting the maxilla is uncommon; however, more virulent fungi, like Mucor, can get past this obstacle. The rhinomaxillary region and patients with immunocompromised conditions, such as diabetes, are susceptible to the common form of this infection, that has a high fatality rate and rapid tissue destruction. Therefore, lowering the death rate depends critically on early detection of this potentially fatal illness and timely treatment, including surgery and antifungeal medication, and keeping control of diabetes.